Strategic partnerships Genentech is actively expanding collaborations in ADC technology and inclusive research networks, signaling opportunities to offer enabling biologics, analytics, or platform services to support joint development programs and broaden clinical trial reach.

Advanced therapies With recent and ongoing ADC collaborations and a history of HER2-targeted therapy leadership, there is potential to present next-gen payload platforms, manufacturing scalability solutions, and companion diagnostic capabilities to strengthen precision oncology offerings.

Scale and reach Genentech operates at a large scale with substantial revenue and a broad global footprint, creating demand for enterprise technology, data management, and secure collaboration tools that integrate with existing systems and workflows.

Patient-centric focus A strong emphasis on patient resources and Inclusive Research initiatives indicates opportunities to offer patient engagement platforms, real-world data analytics, and patient support services that enhance trial access and adherence.

Innovation ecosystem Continuous investment in cutting-edge science and partnerships suggests a need for research-enabled services, such as cloud-based collaboration, AI-driven discovery support, and scalable R&D infrastructure to accelerate programs.